Treatment OutcomePrognosisRetrospective StudiesOutcome Assessment (Health Care)Follow-Up StudiesProspective StudiesSurvival RateSurvival AnalysisRisk FactorsTime FactorsKaplan-Meier EstimateCohort StudiesPregnancy OutcomeMultivariate AnalysisSeverity of Illness IndexPredictive Value of TestsProportional Hazards ModelsRisk AssessmentOutcome and Process Assessment (Health Care)StrokePostoperative ComplicationsAge FactorsGlasgow Outcome ScaleRecurrenceHospital MortalityLogistic ModelsLength of StayNeoplasm StagingRegistriesChi-Square DistributionInfant, NewbornAcute DiseaseRandomized Controlled Trials as TopicDisease-Free SurvivalUnited StatesQuality of LifeBreast NeoplasmsTumor Markers, BiologicalMyocardial InfarctionHeart FailureHospitalizationCombined Modality TherapyCritical IllnessCerebral HemorrhageOdds RatioSex FactorsResuscitationReoperationIncidenceIntensive Care UnitsDisease ProgressionBrain InjuriesBiological MarkersStatistics, NonparametricPatient AdmissionBrain IschemiaFibrinolytic AgentsCoronary Artery BypassAnalysis of VarianceAngioplasty, Balloon, CoronaryPatient SelectionRegression AnalysisGraft SurvivalTreatment FailureTissue DonorsPregnancyPostoperative PeriodHealthcare DisparitiesAntineoplastic Combined Chemotherapy ProtocolsTissue Array AnalysisImmunohistochemistryChemotherapy, AdjuvantLiver TransplantationNeoplasm Recurrence, LocalDouble-Blind MethodTissue Plasminogen ActivatorCase-Control StudiesChronic DiseaseComorbidityRespiration, ArtificialPrevalenceHyperglycemiaStentsDiabetes ComplicationsGraft RejectionSepsisKidney Failure, ChronicGene Expression Regulation, NeoplasticReceptor, erbB-2Receptors, ProgesteroneKidney TransplantationTomography, X-Ray ComputedLymphatic MetastasisAfrican AmericansLung NeoplasmsRecovery of FunctionLeukemia, Myeloid, AcuteNeoplasm InvasivenessPrecursor Cell Lymphoblastic Leukemia-LymphomaReceptors, Estrogen